Bayesian Health Real-Time Clinical Intelligence Platform
AI layer that makes your EHR clinically intelligent with proactive patient monitoring
Company profile
Company profile
Bayesian Health is a clinical AI company that delivers real-time intelligence to healthcare providers, enabling proactive patient care at scale. Founded by Dr. Suchi Saria, a machine learning expert and health AI pioneer, the company was motivated by personal loss and decades of academic research to harness patient data for empowering care teams with actionable clinical signals. The platform serves as an AI layer that makes EHR systems clinically intelligent by reasoning like a clinician—integrating signals across the full patient chart, adjusting to each patient's baseline, and delivering early, targeted clinical guidance instead of noisy one-size-fits-all warnings. Bayesian Health's technology addresses top drivers of mortality and hospital utilization including sepsis, readmissions, patient deterioration, palliative care needs, transitions of care, heart failure, hospital-acquired pressure injuries, and malnutrition. The platform achieves 81% clinician adoption across customers live for 6+ months, with proven outcomes including 5.5% absolute mortality reduction and 1.9-day length of stay reduction in real-world data. The company has received FDA clearance for continuous AI sepsis monitoring and partners with leading health systems including Cleveland Clinic, where the platform achieved a 10x decrease in false alerts, 46% increase in identified sepsis cases, and 7x rise in cases alerted before antibiotics. Bayesian Health's approach is grounded in decades of peer-reviewed research and rigorous validation, focusing on supporting better real-time clinical judgment in the moments that matter most.
Company description Bayesian Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Hybrid deployment with recorded integration context.
Recorded integration context: Epic.
Company milestones
FDA clearance received for continuous AI sepsis monitoring. Cleveland Clinic deployed sepsis module enterprise-wide. Published 5-site study in Nature Medicine demonstrating mortality reduction.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI layer that makes your EHR clinically intelligent with proactive patient monitoring
Hospital-acquired pressure injury prevention and early detection
Ensures appropriate therapy for heart failure patients at discharge
Identifies and documents hospital malnutrition cases
Identifies patients who would benefit from palliative care services
Early detection of clinical deterioration to prevent unplanned ICU admissions
Proactive identification of patients at risk for 30-day readmission
FDA-cleared continuous AI sepsis detection with 3+ hour earlier lead time and 20x lower flag volume
Optimizes care transitions and post-acute care planning
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
The American journal of bioethics : AJOB · Jul 21, 2026
Clear by Design: Consensus-Based Transparency Practices to Foster Trust in Health AI.The American journal of bioethics : AJOB · Jul 21, 2026
Principles to guide clinical AI readiness and move from benchmarks to real-world evaluation.Nature medicine · Mar 1, 2026
Bridging the Gap: Consensus-Based Considerations for AI Usefulness in Healthcare.The American journal of bioethics : AJOB · Feb 1, 2026
Optimal Vasopressin Initiation in Septic Shock: The OVISS Reinforcement Learning Study.JAMA · May 20, 2025
The MI-CLAIM-GEN checklist for generative artificial intelligence in health.Nature medicine · May 1, 2025
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Average across Bayesian Health clients live 6+ months
Real-world data across Bayesian customers
Real-world data across Bayesian customers
5-site study published in Nature Medicine
5-site study published in Nature Medicine
5-site study published in Nature Medicine
Cleveland Clinic sepsis module implementation
Cleveland Clinic sepsis module implementation
Cleveland Clinic sepsis module implementation
Compared to EHR-based algorithms
Compared to EHR-based algorithms
Real-world deployment of clinical intelligence platform across multiple health systems
81% clinician adoption, 5.5% absolute mortality reduction, 1.9 days length of stay reduction
Enterprise-wide sepsis detection and monitoring using Bayesian's sepsis module
10x decrease in false alerts, 46% increase in identified sepsis cases, 7x rise in cases alerted before antibiotics
Comparison study showing Bayesian's superior performance vs EHR-based sepsis detection
3+ hour earlier lead time, 20x lower flag volume compared to Epic sepsis algorithm, less than 1% adoption of previous tools vs 81%+ with Bayesian
Sepsis mortality reduction study published in Nature Medicine
89% adoption, 3.3% absolute mortality reduction, 0.5 days length of stay reduction
05 · Leadership
Leadership profiles and professional links from the current Company record.
Dr. Suchi Saria
Founder & CEO
Conrad Gleber
Associate Chief Medical Information Officer
06 · Company updates
Recent articles published on Bayesian Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing generative AI platforms, large language models (LLMs), foundation models, or broad AI infrastructure specifically designed for healthcare applications. These companies serve multiple clinical use cases across the health system rather than focusing on a single clinical application or disease area.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.